yeah, he would have won the TC if Stuart Elliot didn't get him involved in a speed duel with Eddington, Rock Hard Ten and Limehouse. Oh well.
....will only get better from here. Now that they have signed two big names, others will follow. Speed to maket drugs is very important in this competitive landscape and ONVO's tissue models will become the gold standard. Very bright future
Sentiment: Strong Buy
So where have these FDA approvals been all along? Two in 2 weeks is very surprising. New CEO, new name and 2 approvals.....????
.......this is big pharma. Now that there is no competition how much would you like for your share of the 40 Bn liver disease market??? We don't want a bidding war so just name your price.
Back in January when OCA was awarded BT status by FDA the stock traded up to 221 AH/PM and ended the day down around 190 as I recall. So this pull back from the 325 PM is similar and just reflects market trading. We are given another buying opportunity ahead of the P3 trial start. No question in my mind that this stock will be much higher by year end.
When does the big Pharma partnership get announced???? They are not going to sit back and watch a 40 Bn market fall to ICPT (and GNFT, albeit a smaller share).
If you haven't noticed Its a big market. There is plenty of room for two players to do well. Stop being jealous of others and remember who saved your #$%$ in WWII and liberated your great city from those who marched through the Arc d' Triumph so that I could enjoy it on my honeymoon.
on the path to approval......Phase 3 to begin before June 30. Whatever the price will be today, it most certainly be much higher a year from now when OCA is on the market.
If their trials are successful both Genfit and Intercept will do well. As an example, look at the huge battle brewing between REGN and AMGN in the cholesterol drug market for the new PCSK9 antibodies. If everyone was so worried about this competition, you wouldn't see both REGN and AMGN stocks doing well as their antibody drugs will come to market this summer. Similarly, I'm not worried about being long ICPT if and when both ICPT and GNFT drugs come to market.
There will be lots of volatility as MM take out stop lose orders but I agree that the pps will trend higher. There was huge volume yesterday in the March 20 call options which expire next week so..........